3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Active not recruiting
1
Sponsor
Conditions
Ovarian Neoplasms
10
Neoplasms
3
Fallopian Tube Neoplasms
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Brain Neoplasms
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
SCLC,Extensive Stage
1
Rare Tumor
1
Penile Neoplasms
1
Pathologic Complete Response
1
Pancreatic Adenocarcinoma Metastatic
1
Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
1
Ovarian Carcinosarcoma
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Hemangiosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Cystadenocarcinoma, Serous
1
Carcinoma, Ovarian Epithelial
1
Carcinoma
1
Biliary Tract Neoplasms
1
Advanced Solid Tumor
1
Interventions
pembrolizumab
12
Cisplatin
7
Cetuximab
7
Carboplatin
7
Docetaxel
6
Blood Specimen Collection
4
Radiotherapy, Intensity-Modulated
3
Paclitaxel
3
toripalimab
2
atezolizumab
2
Radiotherapy
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Fluorouracil
2
Drug Therapy
2
tocilizumab
1
regorafenib
1
osimertinib
1
lenvatinib
1
fludarabine
1
ficlatuzumab
1
cemiplimab
1
calcipotriene
1
bintrafusp alfa protein, human
1
avelumab
1
alpha-2'-deoxythioguanosine
1
aldesleukin
1
aflibercept
1
Watchful Waiting
1
Vinorelbine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recruiting
×
Carcinoma, Squamous Cell
×
niraparib
×
Clear all
No trials found.